Phase I Study of SC-43 Oral Solution in Subjects With Refractory Solid Tumors
Phase 1
Withdrawn
- Conditions
- Refractory Solid Tumor
- Interventions
- Drug: SC-43 Oral Solution
- First Posted Date
- 2018-02-23
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- SupremeCure Pharma Inc.
- Registration Number
- NCT03443622
© Copyright 2025. All Rights Reserved by MedPath